<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250629066291N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-05-18</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Added Value of Diaphragmatic Myofascial Release in the Management of Chronic Tension-Type Headache</public_title>
      <acronym></acronym>
      <scientific_title>Added Value of Diaphragmatic Myofascial Release in the Management of Chronic Tension-Type Headache: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-06-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>22</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/89223</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The random assignment method in this study will be the blocked permutation method (number of blocks 8 and block size 4) which will be generated using randomizer site The samples will be assigned in a 1:1 ratio. Opaque, sealed envelopes will be used to conceal the assignment, Blinding description: The individual who performs the assessments is separate from the one who administers the treatments, and neither is aware of the other's work. The person responsible for randomization is also independent from both of the aforementioned individuals.</study_design>
      <phase>3</phase>
      <hc_freetext>tension-type headache.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: diaphragm release and suboccipital release: To release the diaphragm, the patient is positioned in the supine position. The therapist stands at the head of the patient. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ) with hypothenar regions of the hands and last three fingers. During the patient’s inspiration, the therapist is gently pulling the points of hands contacts toward the head and slightly laterally, while elevating the ribs simultaneously. During exhalation, the therapist deepens hand contacts towards the inner costal margins. The release technique is performed thrice a week for two weeks; each technique lasts for 5 to 7 minutes. All release techniques will be done by the same physiotherapist. For suboccipital release technique, the patient is asked to lie down in a relaxed supine position on the treatment table while the therapist sits on a chair at the head of the patient. The therapist's elbows are supported by the table, and their forearms are positioned in supination. The patient is then instructed to rest their head on the therapist's palms. Next, the therapist places the pads of four fingers of both hands on either side of the C2 vertebra, just below the occipital region, and applies pressure until a melting sensation is felt. The intervention lasts four minutes. During this technique, the patient is asked to close both eyes to prevent eye movements, which could affect the tone of the sub occipital muscles. This technique is performed three times a week for two weeks for each patient in this group. Intervention 2: Intervention group: For suboccipital release technique, the patient is asked to lie down in a relaxed supine position on the treatment table while the therapist sits on a chair at the head of the patient. The therapist's elbows are supported by the table, and their forearms are positioned in supination. The patient is then instructed to rest their head on the therapist's palms. Next, the therapist places the pads of four fingers of both hands on either side of the C2 vertebra, just below the occipital region, and applies pressure until a melting sensation is felt. The intervention lasts four minutes. During this technique, the patient is asked to close both eyes to prevent eye movements, which could affect the tone of the sub occipital muscles. This technique is performed three times a week for two weeks for each patient in this group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
information collection form including primary and secondary outcomes, informed consent form and SSPS file.

When:
After publication of the results of the study

To whom:
Researchers working in academic and scientific institutions

Conditions:
Only for recording information in scientific databases

Where to obtain:
correspondence with the project manager by email.
 Haghighat_fa@yahoo.com

How to obtain:
Maximum one month after sending the request by email.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farzaneh Haghighat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Chamran Blvd</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194815644</zip>
        <telephone>+98 71 3230 5410</telephone>
        <email>Haghighat_fa@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farzaneh Haghighat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Chamran Blvd</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194815644</zip>
        <telephone>+98 71 3230 5410</telephone>
        <email>Haghighat_fa@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range: 18 to 40 years
Headache lasting from 30 min to 7 days.
3.	At least two of the following pain characteristics:1. Bilateral location2. Pressing or tightening (non-pulsating) quality 3. Mild or moderate intensity 4. Not aggravated by routine physical activity, such as walking or climbing stairs
People with CTTH who had headache for at least 3 days in a week for the past four Consecutive weeks
No nausea, vomiting (anorexia can occur)
No more than one of photophobia or phonophobia not attributed to another disorder</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Visual or hearing impairment
Nervous system disorders
Balance disorders
cervical disk herniation
History of surgery in the neck and spine area
A history of additional migraine headache or secondary headaches
History of any trauma to the cervical spine, such as whiplash injury
Cognitive disorders
Inflammatory diseases such as rheumatoid arthritis
History of any fracture in the neck area
Congenital neck abnormalities (torticollis)
Respiratory diseases and shingles
Professional athletes
Cervical spinal canal stenosis
Radicular pain related to the neck area
Malignancy
Fibromyalgia
pregnant or breastfeeding
Undergoing physiotherapy treatment within the last six months
Use of painkillers, anti-inflammatory drugs, or muscle relaxants within the past 72 hours</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G44.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Tension-type headache</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: diaphragm release and suboccipital release: To release the diaphragm, the patient is positioned in the supine position. The therapist stands at the head of the patient. The therapist makes manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th ) with hypothenar regions of the hands and last three fingers. During the patient’s inspiration, the therapist is gently pulling the points of hands contacts toward the head and slightly laterally, while elevating the ribs simultaneously. During exhalation, the therapist deepens hand contacts towards the inner costal margins. The release technique is performed thrice a week for two weeks; each technique lasts for 5 to 7 minutes. All release techniques will be done by the same physiotherapist. For suboccipital release technique, the patient is asked to lie down in a relaxed supine position on the treatment table while the therapist sits on a chair at the head of the patient. The therapist's elbows are supported by the table, and their forearms are positioned in supination. The patient is then instructed to rest their head on the therapist's palms. Next, the therapist places the pads of four fingers of both hands on either side of the C2 vertebra, just below the occipital region, and applies pressure until a melting sensation is felt. The intervention lasts four minutes. During this technique, the patient is asked to close both eyes to prevent eye movements, which could affect the tone of the sub occipital muscles. This technique is performed three times a week for two weeks for each patient in this group.</i_keyword>
      <i_keyword>Intervention group: For suboccipital release technique, the patient is asked to lie down in a relaxed supine position on the treatment table while the therapist sits on a chair at the head of the patient. The therapist's elbows are supported by the table, and their forearms are positioned in supination. The patient is then instructed to rest their head on the therapist's palms. Next, the therapist places the pads of four fingers of both hands on either side of the C2 vertebra, just below the occipital region, and applies pressure until a melting sensation is felt. The intervention lasts four minutes. During this technique, the patient is asked to close both eyes to prevent eye movements, which could affect the tone of the sub occipital muscles. This technique is performed three times a week for two weeks for each patient in this group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: before intervention, after intervention period. Method of measurement: numerical pain rating scale.</prim_outcome>
      <prim_outcome>Headache frequency. Timepoint: 4 weeks before intervention, 1 week after intervention period. Method of measurement: interview and headache records.</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: before intervention, 1 week after intervention. Method of measurement: headache disability index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-10</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Ethics committee, Research and Technology Vice-Chancellor, 7th floor, Central building of Shiraz University of Medical Sciences, Zand Street Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
